A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
- PMID: 27094857
- DOI: 10.1007/s10048-016-0482-4
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
Abstract
Exome sequencing is an effective way to identify genetic causes of etiologically heterogeneous conditions such as developmental delay and intellectual disabilities. Using exome sequencing, we have identified four patients with similar phenotypes of developmental delay, intellectual disability, failure to thrive, hypotonia, ataxia, and tooth enamel defects who all have the same de novo R331W missense variant in C-terminal binding protein 1 (CTBP1). CTBP1 is a transcriptional regulator critical for development by coordinating different regulatory pathways. The R331W variant found in these patients is within the C-terminal portion of the PLDLS (Pro-Leu-Asp-Leu-Ser) binding cleft, which is the domain through which CTBP1, interacts with chromatin-modifying enzymes and mediates chromatin-dependent gene repression pathways. This is the first report of mutations within CTBP1 in association with any human disease.
Keywords: Ataxia; CTBP1; Chromatin; Developmental delay; Enamel defects; Hypotonia; Whole exome sequencing.
Similar articles
-
CTBP1 and CTBP2 mutations underpinning neurological disorders: a systematic review.Neurogenetics. 2022 Oct;23(4):231-240. doi: 10.1007/s10048-022-00700-w. Epub 2022 Nov 4. Neurogenetics. 2022. PMID: 36331689 Free PMC article. Review.
-
Exome sequencing identified a de novo frameshift pathogenic variant of CTBP1 in an extremely rare case of HADDTS.J Genet. 2021;100:68. J Genet. 2021. PMID: 34608870
-
A further case of hypotonia, ataxia, developmental delay and tooth enamel defect syndrome due to a recurrent C-terminal binding protein 1 mutation.Clin Dysmorphol. 2020 Jul;29(3):148-151. doi: 10.1097/MCD.0000000000000321. Clin Dysmorphol. 2020. PMID: 32167997 No abstract available.
-
A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity.Neurogenetics. 2019 Aug;20(3):129-143. doi: 10.1007/s10048-019-00578-1. Epub 2019 Apr 30. Neurogenetics. 2019. PMID: 31041561 Free PMC article.
-
Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome.Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6):a002162. doi: 10.1101/mcs.a002162. Print 2017 Nov. Cold Spring Harb Mol Case Stud. 2017. PMID: 28963436 Free PMC article. Review.
Cited by
-
A novel CTBP1 variant in a Chinese pediatric patient with a phenotype distinct from hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome.Front Genet. 2024 Jan 29;15:1344682. doi: 10.3389/fgene.2024.1344682. eCollection 2024. Front Genet. 2024. PMID: 38348454 Free PMC article.
-
Expression Levels of WNT Signaling Pathway Genes During Early Tooth Development.Organogenesis. 2023 Dec 31;19(1):2212583. doi: 10.1080/15476278.2023.2212583. Organogenesis. 2023. PMID: 37194731 Free PMC article. Review.
-
Mitochondrial respiratory chain dysfunction in a patient with a heterozygous de novo CTBP1 variant.JIMD Rep. 2022 Aug 24;63(6):546-554. doi: 10.1002/jmd2.12326. eCollection 2022 Nov. JIMD Rep. 2022. PMID: 36341169 Free PMC article.
-
CTBP1 and CTBP2 mutations underpinning neurological disorders: a systematic review.Neurogenetics. 2022 Oct;23(4):231-240. doi: 10.1007/s10048-022-00700-w. Epub 2022 Nov 4. Neurogenetics. 2022. PMID: 36331689 Free PMC article. Review.
-
Mitochondrial Dysfunction: A Common Denominator in Neurodevelopmental Disorders?Dev Neurosci. 2021;43(3-4):222-229. doi: 10.1159/000517870. Epub 2021 Aug 3. Dev Neurosci. 2021. PMID: 34350863 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials